Compile Data Set for Download or QSAR
Found 880 of ki data for polymerid = 11215,11216,1385,1386,1387,1388,1389,1390,1391,1392,1393,195,3703,5221
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112421(US8623889, 420)copy SMILEScopy InChI
Affinity DataKi:  0.0186nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM50303233(2-(3-aminophenylamino)-6-(2,6-dichlorophenyl)-8-me...)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Inhibition of recombinant c-Abl after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CZ384XPubMed
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM50378812(CHEMBL1221411)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Inhibition of recombinant c-Abl after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CZ384XPubMed
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112312(US8623889, 311)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112359(US8623889, 358)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112161(US8623889, 159)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112230(US8623889, 228)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112066(US8623889, 64)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112111(US8623889, 109)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112193(US8623889, 191)copy SMILEScopy InChI
Affinity DataKi:  0.0200nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112288(US8623889, 286)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112289(US8623889, 287)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112251(US8623889, 249)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112274(US8623889, 272)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112106(US8623889, 104)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112029(US8623889, 27)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112099(US8623889, 97)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112105(US8623889, 103)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112275(US8623889, 273)copy SMILEScopy InChI
Affinity DataKi:  0.0300nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112192(US8623889, 190)copy SMILEScopy InChI
Affinity DataKi:  0.0400nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112144(US8623889, 142)copy SMILEScopy InChI
Affinity DataKi:  0.0400nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112032(US8623889, 30)copy SMILEScopy InChI
Affinity DataKi:  0.0400nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112252(US8623889, 250)copy SMILEScopy InChI
Affinity DataKi:  0.0400nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112244(US8623889, 242)copy SMILEScopy InChI
Affinity DataKi:  0.0500nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112255(US8623889, 253)copy SMILEScopy InChI
Affinity DataKi:  0.0500nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112245(US8623889, 243)copy SMILEScopy InChI
Affinity DataKi:  0.0500nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112254(US8623889, 252)copy SMILEScopy InChI
Affinity DataKi:  0.0600nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112078(US8623889, 76)copy SMILEScopy InChI
Affinity DataKi:  0.0600nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM50221547(4-chloro-3-(5-methyl-3-(4-(3-(pyrrolidin-1-yl)prop...)copy SMILEScopy InChI
Affinity DataKi:  0.0620nMAssay Description:Inhibition of AblMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32VGMPubMed
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM50615340(CHEMBL5282076)copy SMILES
Affinity DataKi:  0.0620nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112289(US8623889, 287)copy SMILEScopy InChI
Affinity DataKi:  0.0700nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112065(US8623889, 63)copy SMILEScopy InChI
Affinity DataKi:  0.0700nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112194(US8623889, 192)copy SMILEScopy InChI
Affinity DataKi:  0.0700nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112157(US8623889, 155)copy SMILEScopy InChI
Affinity DataKi:  0.0700nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112288(US8623889, 286)copy SMILEScopy InChI
Affinity DataKi:  0.0700nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112379(US8623889, 378)copy SMILEScopy InChI
Affinity DataKi:  0.0709nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112418(US8623889, 417)copy SMILEScopy InChI
Affinity DataKi:  0.0723nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112439(US8623889, 438)copy SMILEScopy InChI
Affinity DataKi:  0.0799nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112438(US8623889, 437)copy SMILEScopy InChI
Affinity DataKi:  0.0799nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112330(US8623889, 329)copy SMILEScopy InChI
Affinity DataKi:  0.0800nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112408(US8623889, 407)copy SMILEScopy InChI
Affinity DataKi:  0.0841nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112409(US8623889, 408)copy SMILEScopy InChI
Affinity DataKi:  0.0841nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112425(US8623889, 424)copy SMILEScopy InChI
Affinity DataKi:  0.0896nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112191(US8623889, 189)copy SMILEScopy InChI
Affinity DataKi:  0.0900nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112224(US8623889, 222)copy SMILEScopy InChI
Affinity DataKi:  0.0900nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112244(US8623889, 242)copy SMILEScopy InChI
Affinity DataKi:  0.0900nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112107(US8623889, 105)copy SMILEScopy InChI
Affinity DataKi:  0.0900nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112057(US8623889, 55)copy SMILEScopy InChI
Affinity DataKi:  0.0900nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112058(US8623889, 56)copy SMILEScopy InChI
Affinity DataKi:  0.0900nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Genentech, Inc.

US Patent
LigandPNGBDBM112245(US8623889, 243)copy SMILEScopy InChI
Affinity DataKi:  0.0900nMAssay Description:Using the following procedure, varying concentration of compounds of the invention were assessed for their ability to inhibit c-Abl enzyme's phos...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JQ0ZNXUS Patent
Displayed 1 to 50 (of 880 total ) | Next | Last >>
Jump to: